This study aims to understand the effectiveness of the combination of 2 medications to treat cocaine addiction. The two medications are extended-release naltrexone and extended-release buprenorphine.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
Cocaine User
18-65 Years Old
Considering stopping or reducing cocaine use
Participants in this study will receive a total of 5 injections over 8 weeks. Participants will be randomly assigned to receive either: 1) the two medications mentioned or 2) placebo injections.
Compensation up to $968 is provided for participation in the study.
Study participants will be provided with study medication and study related procedures at no cost to them or their insurance.